Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep123

Hypocretin 1 and 2 (Hcrts; also known as orexin A and B), excitatory neuropeptides synthesized in cells located in the tuberal hypothalamus, play a central role in the control of arousal. Hcrt inputs to the locus coeruleus norepinephrine (LC NE) system and the posterior hypothalamic histaminergic tu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:eNeuro 2016-03, Vol.3 (2)
Hauptverfasser: Schwartz, Michael D., Nguyen, Alexander T., Warrier, Deepti R., Palmerston, Jeremiah B., Thomas, Alexia M., Morairty, Stephen R., Neylan, Thomas C., Kilduff, Thomas S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 2
container_start_page
container_title eNeuro
container_volume 3
creator Schwartz, Michael D.
Nguyen, Alexander T.
Warrier, Deepti R.
Palmerston, Jeremiah B.
Thomas, Alexia M.
Morairty, Stephen R.
Neylan, Thomas C.
Kilduff, Thomas S.
description Hypocretin 1 and 2 (Hcrts; also known as orexin A and B), excitatory neuropeptides synthesized in cells located in the tuberal hypothalamus, play a central role in the control of arousal. Hcrt inputs to the locus coeruleus norepinephrine (LC NE) system and the posterior hypothalamic histaminergic tuberomammillary nuclei (TMN HA) are important efferent pathways for Hcrt-induced wakefulness. The LC expresses Hcrt receptor 1 (HcrtR1), whereas HcrtR2 is found in the TMN. Although the dual Hcrt/orexin receptor antagonist almorexant (ALM) decreases wakefulness and increases NREM and REM sleep time, the neural circuitry that mediates these effects is currently unknown. To test the hypothesis that ALM induces sleep by selectively disfacilitating subcortical wake-promoting populations, we ablated LC NE neurons (LCx) or TMN HA neurons (TMNx) in rats using cell-type-specific saporin conjugates and evaluated sleep/wake following treatment with ALM and the GABA A receptor modulator zolpidem (ZOL). Both LCx and TMNx attenuated the promotion of REM sleep by ALM without affecting ALM-mediated increases in NREM sleep. Thus, eliminating either HcrtR1 signaling in the LC or HcrtR2 signaling in the TMN yields similar effects on ALM-induced REM sleep without affecting NREM sleep time. In contrast, neither lesion altered ZOL efficacy on any measure of sleep–wake regulation. These results contrast with those of a previous study in which ablation of basal forebrain cholinergic neurons attenuated ALM-induced increases in NREM sleep time without affecting REM sleep, indicating that Hcrt neurotransmission influences distinct aspects of NREM and REM sleep at different locations in the sleep–wake regulatory network.
doi_str_mv 10.1523/ENEURO.0018-16.2016
format Article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4801942</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4801942</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_48019423</originalsourceid><addsrcrecordid>eNqljctKw0AYhQdB2qJ9AjfzAkln_qlJ3AihRLqwLdR2HSbJbx2ZS5iL2Lc3CzeuXZ0D38c5hDxwlvNHEKtm35yPh5wxXmW8yIHx4oYsQJQigwpgTpYhfLIJF1Dyis_IHEoGUAi-IP7V9SnQjUOfNE5N2oGeUofeGWmM0lr6K92nXqOidadlVM4GWseINsmIdHsdXe8xKrs6ePxWltY2youzKsRsh4OapIEemx1904gjB3FPbt-lDrj8zTvy_NKcNttsTJ3BoUcbvdTt6JWZvlsnVfuXWPXRXtxXu64Yf1qD-PfAD0RGajk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep123</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Schwartz, Michael D. ; Nguyen, Alexander T. ; Warrier, Deepti R. ; Palmerston, Jeremiah B. ; Thomas, Alexia M. ; Morairty, Stephen R. ; Neylan, Thomas C. ; Kilduff, Thomas S.</creator><creatorcontrib>Schwartz, Michael D. ; Nguyen, Alexander T. ; Warrier, Deepti R. ; Palmerston, Jeremiah B. ; Thomas, Alexia M. ; Morairty, Stephen R. ; Neylan, Thomas C. ; Kilduff, Thomas S.</creatorcontrib><description>Hypocretin 1 and 2 (Hcrts; also known as orexin A and B), excitatory neuropeptides synthesized in cells located in the tuberal hypothalamus, play a central role in the control of arousal. Hcrt inputs to the locus coeruleus norepinephrine (LC NE) system and the posterior hypothalamic histaminergic tuberomammillary nuclei (TMN HA) are important efferent pathways for Hcrt-induced wakefulness. The LC expresses Hcrt receptor 1 (HcrtR1), whereas HcrtR2 is found in the TMN. Although the dual Hcrt/orexin receptor antagonist almorexant (ALM) decreases wakefulness and increases NREM and REM sleep time, the neural circuitry that mediates these effects is currently unknown. To test the hypothesis that ALM induces sleep by selectively disfacilitating subcortical wake-promoting populations, we ablated LC NE neurons (LCx) or TMN HA neurons (TMNx) in rats using cell-type-specific saporin conjugates and evaluated sleep/wake following treatment with ALM and the GABA A receptor modulator zolpidem (ZOL). Both LCx and TMNx attenuated the promotion of REM sleep by ALM without affecting ALM-mediated increases in NREM sleep. Thus, eliminating either HcrtR1 signaling in the LC or HcrtR2 signaling in the TMN yields similar effects on ALM-induced REM sleep without affecting NREM sleep time. In contrast, neither lesion altered ZOL efficacy on any measure of sleep–wake regulation. These results contrast with those of a previous study in which ablation of basal forebrain cholinergic neurons attenuated ALM-induced increases in NREM sleep time without affecting REM sleep, indicating that Hcrt neurotransmission influences distinct aspects of NREM and REM sleep at different locations in the sleep–wake regulatory network.</description><identifier>EISSN: 2373-2822</identifier><identifier>DOI: 10.1523/ENEURO.0018-16.2016</identifier><identifier>PMID: 27022631</identifier><language>eng</language><publisher>Society for Neuroscience</publisher><subject>New Research</subject><ispartof>eNeuro, 2016-03, Vol.3 (2)</ispartof><rights>Copyright © 2016 Schwartz et al. 2016 Schwartz et al.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801942/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801942/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids></links><search><creatorcontrib>Schwartz, Michael D.</creatorcontrib><creatorcontrib>Nguyen, Alexander T.</creatorcontrib><creatorcontrib>Warrier, Deepti R.</creatorcontrib><creatorcontrib>Palmerston, Jeremiah B.</creatorcontrib><creatorcontrib>Thomas, Alexia M.</creatorcontrib><creatorcontrib>Morairty, Stephen R.</creatorcontrib><creatorcontrib>Neylan, Thomas C.</creatorcontrib><creatorcontrib>Kilduff, Thomas S.</creatorcontrib><title>Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep123</title><title>eNeuro</title><description>Hypocretin 1 and 2 (Hcrts; also known as orexin A and B), excitatory neuropeptides synthesized in cells located in the tuberal hypothalamus, play a central role in the control of arousal. Hcrt inputs to the locus coeruleus norepinephrine (LC NE) system and the posterior hypothalamic histaminergic tuberomammillary nuclei (TMN HA) are important efferent pathways for Hcrt-induced wakefulness. The LC expresses Hcrt receptor 1 (HcrtR1), whereas HcrtR2 is found in the TMN. Although the dual Hcrt/orexin receptor antagonist almorexant (ALM) decreases wakefulness and increases NREM and REM sleep time, the neural circuitry that mediates these effects is currently unknown. To test the hypothesis that ALM induces sleep by selectively disfacilitating subcortical wake-promoting populations, we ablated LC NE neurons (LCx) or TMN HA neurons (TMNx) in rats using cell-type-specific saporin conjugates and evaluated sleep/wake following treatment with ALM and the GABA A receptor modulator zolpidem (ZOL). Both LCx and TMNx attenuated the promotion of REM sleep by ALM without affecting ALM-mediated increases in NREM sleep. Thus, eliminating either HcrtR1 signaling in the LC or HcrtR2 signaling in the TMN yields similar effects on ALM-induced REM sleep without affecting NREM sleep time. In contrast, neither lesion altered ZOL efficacy on any measure of sleep–wake regulation. These results contrast with those of a previous study in which ablation of basal forebrain cholinergic neurons attenuated ALM-induced increases in NREM sleep time without affecting REM sleep, indicating that Hcrt neurotransmission influences distinct aspects of NREM and REM sleep at different locations in the sleep–wake regulatory network.</description><subject>New Research</subject><issn>2373-2822</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqljctKw0AYhQdB2qJ9AjfzAkln_qlJ3AihRLqwLdR2HSbJbx2ZS5iL2Lc3CzeuXZ0D38c5hDxwlvNHEKtm35yPh5wxXmW8yIHx4oYsQJQigwpgTpYhfLIJF1Dyis_IHEoGUAi-IP7V9SnQjUOfNE5N2oGeUofeGWmM0lr6K92nXqOidadlVM4GWseINsmIdHsdXe8xKrs6ePxWltY2youzKsRsh4OapIEemx1904gjB3FPbt-lDrj8zTvy_NKcNttsTJ3BoUcbvdTt6JWZvlsnVfuXWPXRXtxXu64Yf1qD-PfAD0RGajk</recordid><startdate>20160321</startdate><enddate>20160321</enddate><creator>Schwartz, Michael D.</creator><creator>Nguyen, Alexander T.</creator><creator>Warrier, Deepti R.</creator><creator>Palmerston, Jeremiah B.</creator><creator>Thomas, Alexia M.</creator><creator>Morairty, Stephen R.</creator><creator>Neylan, Thomas C.</creator><creator>Kilduff, Thomas S.</creator><general>Society for Neuroscience</general><scope>5PM</scope></search><sort><creationdate>20160321</creationdate><title>Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep123</title><author>Schwartz, Michael D. ; Nguyen, Alexander T. ; Warrier, Deepti R. ; Palmerston, Jeremiah B. ; Thomas, Alexia M. ; Morairty, Stephen R. ; Neylan, Thomas C. ; Kilduff, Thomas S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_48019423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>New Research</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schwartz, Michael D.</creatorcontrib><creatorcontrib>Nguyen, Alexander T.</creatorcontrib><creatorcontrib>Warrier, Deepti R.</creatorcontrib><creatorcontrib>Palmerston, Jeremiah B.</creatorcontrib><creatorcontrib>Thomas, Alexia M.</creatorcontrib><creatorcontrib>Morairty, Stephen R.</creatorcontrib><creatorcontrib>Neylan, Thomas C.</creatorcontrib><creatorcontrib>Kilduff, Thomas S.</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>eNeuro</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schwartz, Michael D.</au><au>Nguyen, Alexander T.</au><au>Warrier, Deepti R.</au><au>Palmerston, Jeremiah B.</au><au>Thomas, Alexia M.</au><au>Morairty, Stephen R.</au><au>Neylan, Thomas C.</au><au>Kilduff, Thomas S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep123</atitle><jtitle>eNeuro</jtitle><date>2016-03-21</date><risdate>2016</risdate><volume>3</volume><issue>2</issue><eissn>2373-2822</eissn><abstract>Hypocretin 1 and 2 (Hcrts; also known as orexin A and B), excitatory neuropeptides synthesized in cells located in the tuberal hypothalamus, play a central role in the control of arousal. Hcrt inputs to the locus coeruleus norepinephrine (LC NE) system and the posterior hypothalamic histaminergic tuberomammillary nuclei (TMN HA) are important efferent pathways for Hcrt-induced wakefulness. The LC expresses Hcrt receptor 1 (HcrtR1), whereas HcrtR2 is found in the TMN. Although the dual Hcrt/orexin receptor antagonist almorexant (ALM) decreases wakefulness and increases NREM and REM sleep time, the neural circuitry that mediates these effects is currently unknown. To test the hypothesis that ALM induces sleep by selectively disfacilitating subcortical wake-promoting populations, we ablated LC NE neurons (LCx) or TMN HA neurons (TMNx) in rats using cell-type-specific saporin conjugates and evaluated sleep/wake following treatment with ALM and the GABA A receptor modulator zolpidem (ZOL). Both LCx and TMNx attenuated the promotion of REM sleep by ALM without affecting ALM-mediated increases in NREM sleep. Thus, eliminating either HcrtR1 signaling in the LC or HcrtR2 signaling in the TMN yields similar effects on ALM-induced REM sleep without affecting NREM sleep time. In contrast, neither lesion altered ZOL efficacy on any measure of sleep–wake regulation. These results contrast with those of a previous study in which ablation of basal forebrain cholinergic neurons attenuated ALM-induced increases in NREM sleep time without affecting REM sleep, indicating that Hcrt neurotransmission influences distinct aspects of NREM and REM sleep at different locations in the sleep–wake regulatory network.</abstract><pub>Society for Neuroscience</pub><pmid>27022631</pmid><doi>10.1523/ENEURO.0018-16.2016</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier EISSN: 2373-2822
ispartof eNeuro, 2016-03, Vol.3 (2)
issn 2373-2822
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4801942
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects New Research
title Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep123
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A54%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Locus%20Coeruleus%20and%20Tuberomammillary%20Nuclei%20Ablations%20Attenuate%20Hypocretin/Orexin%20Antagonist-Mediated%20REM%20Sleep123&rft.jtitle=eNeuro&rft.au=Schwartz,%20Michael%20D.&rft.date=2016-03-21&rft.volume=3&rft.issue=2&rft.eissn=2373-2822&rft_id=info:doi/10.1523/ENEURO.0018-16.2016&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4801942%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/27022631&rfr_iscdi=true